Our Product
Based on a PhD thesis, peer-reviewed research, and extensive real-world experience, the technology developed by Zev Health Technologies allows for exercised-based healthcare interventions to join the modern era of progressive, innovation-based technologies.
DATA-DRIVEN
Zev’s proprietary technology tracks user data to allow for healthcare professionals to monitor progression, identify issues, and predict outcomes. Empowered through simple and clear data visualization, our system provides insights unavailable to those following traditional exercise programs.
INDEPENDENCE
Our platform provides a pathway for streaming content, instruction, gamification, social engagement, and achievements to train, entertain, and maintain motivation without the need for specially trained staff to provide exercise classes.
MULTI-USE
Whether focused on the obesity epidemic or neurological disorders such as Parkinson’s Disease, Zev’s combat-based platform allows for safe, monitored training that is evidenced-based in treating health care issues.
About us
Zev Health is an US-founded company with a distributed team of experts from diverse backgrounds working in an agile and lean environment to create cutting-edge tools for assessment, analysis, and rehabilitation in the healthcare field.
Zev Health focuses on rehabilitation products and consulting
services ranging from customized hardware, software, and deployment services along with one-on-one and one-to-many training and coaching services.
Leadership
Seth Lenetsky
CEO, FOUNDER & CO-CHAIRMAN OF THE BOARD
PhD in strength and conditioning and sports biomechanics focused on sports combat. Published peer-reviewed articles on impact sciences and experience with high-performance athletes.
Steve Graham
CTO & FOUNDER
Full stack developer with 20 years experience in hardware, firmware, systems architecture, user interface design, prototyping and development. Confident leader with track record of growing and developing productive teams.
Peter Irby
CDO & Founder
Seasoned creative professional with 15 years of experience across a wide range of fields from advertising to in house creative services.
lynn Fischer
COO
Lynn Fischer has over twenty-five years as a technology executive in the telecommunications and healthcare industries. Her passion has been envisioning and implementing new technology and business approaches to support the transformation of large enterprises and develop the people and teams to support the changes.
Advisory Board
Dr. John Serak
neurosurgeon
Dr. Serak is a neurosurgeon with a focus on the treatment of spinal disorders. He is specifically interested in Minimally Invasive Surgery (MIS), which minimizes damage to the muscle surrounding the spine and preserves normal parts of the spine. This results in patients spending less time in the hospital after surgery, less narcotic pain medication and faster return to work/normal activities when compared to non-minimally invasive techniques. He utilizes cutting edge technology including robotic spine surgery and endoscopic spine surgery. Dr. Serak also has a strong interest in spinal trauma, traumatic head injury and concussion, and treats patients at level I and level II trauma centers in Denver. Additionally, he has experience in the surgical treatment of movement disorders, including Parkinson Disease, as well as treatment of patients with concurrent PD and spinal issues such as spinal stenosis and spinal cord compression and injury.
Dr. Serak graduated from Wabash College, a small liberal arts school in Indiana, with a Bachelor of Arts degree in Biology and Chemistry. He then attended Georgetown University, receiving a Master’s degree in Physiology and Biophysics. Dr. Serak attended medical school at Indiana University School of Medicine. Subsequently, he completed residency in Neurosurgery as well as a fellowship in minimally invasive and complex spine surgery at Jackson Memorial Hospital/Miller School of Medicine in Miami, FL. Dr. Serak currently practices Neurosurgery in Denver, CO. Throughout his career, he has been involved with research in the neurosciences, including research into neural development, genetics and epigenetics of neurons, mapping of neural pathways and clinical neurosurgical research. This research has produced a number of publications in peer-reviewed journals.
Dr. Stephen T. Gancher
neurosurgeon
Dr Grancher served his residency in Portland at Oregon Health and Science University (OHSU) ), and at that time became interested in Parkinson’s disease and academic research. He subsequently joined the OHSU faculty. In 1996 he left OHSU to join Kaiser Permanente in the department of Neurology. He subspecialize in the treatment of Parkinson’s disease and other involuntary movement disorders, and is an expert in the administration of botulinum toxin (Botox) injections for medical illnesses. He is also experienced at treating movement disorder conditions with deep brain stimulation and is experienced at DBS programming, as well as programming vagal nerve stimulation devices for the treatment of epilepsy. In recent years, he has developed a special interest in cerebrovascular disease and serves as the stroke director for Kaiser Sunnyside Medical Center.
Mark Shirman
Adviser
Mark Shirman, has over thirty five years of entrepreneurial experience in the IT services and Software arena. Mark is currently COO of Congruity360 LLC, an infrastructure services company providing services to the data driven enterprise. Prior to Congruity360 Mark was CEO of RiverMeadow Software, a venture backed startup that created a SaaS tool focused on Cloud Migration. Mark was the Founder/CEO of GlassHouse Technologies. At GlassHouse he built the companies leadership position in the infrastructure solutions space, as well as managing the investment community. Glasshouse represented over 600 professionals in 8 countries throughout the world.
Before starting GlassHouse, Mark was Executive Vice President of Corporate Development and CTO at Convergent Group where he executed a combination of operational and marketing strategies that resulted in a successful IPO and the subsequent sale of the business to Schlumberger Corporation. Prior to Convergent Group, Mark was responsible for the worldwide eBusiness and CRM lines of business for Cambridge Technology Partners. Previously, Mark ran similar units for BSG/Alliance IT. In 1985, he successfully launched a new breed IT consulting company called Innovative Information Systems Inc. (IISI) was focused on emerging technologies and application development. Mark served as CEO of IISI until its sale to CDI Corporation in 1990, and then served as its president until 1995.
Mark started his career with Arthur Andersen & Co. after receiving his BA in Economics from Brandeis University and his MBA from American University. Mark served as a member of the Boston Public Library Technology Council, a governor’s appointed Trustee for Wachusett Community College, and a director for Baby’s Breath, a non-profit organization focused connecting infants with loving homes and families. He is currently a Director or Advisor for a variety of technology and startup organizations.
Produced by Zev Health © 2020